INCB040093 and INCB040093 Combined With Itacitinib (INCB039110) in Relapsed/Refractory Hodgkin Lymphoma
Clinical trial NCT02456675 · TERMINATED
Trial details
- NCT number
- NCT02456675
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-12-16
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.